Arialys Therapeutics

Acquisition, funding and merger involving Arialys Therapeutics.

• Arialys Therapeutics has just announced a $58 Million fundraising (posted on September 13 2023).

View the org chart displaying its 7 main executives

Most searched biographies at Arialys Therapeutics

• Jay Lichter, Director, President and Chief Executive Officer
• Asish Xavier, Director
• Bt Slingsby, Co-Founder & Chairman of the Board

Create your alert
to follow the executive moves at Arialys Therapeutics.

Arialys Therapeutics has 2,289 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Arialys Therapeutics

• Arialys Therapeutics
• Arialys Therapeutics
• Arialys Therapeutics
• Arialys Therapeutics
• Arialys Therapeutics
• Arialys Therapeutics
• Arialys Therapeutics
• Arialys Therapeutics
• Arialys Therapeutics
• Arialys Therapeutics
• View more press releases Close

Social media about Arialys Therapeutics

• Arialys Therapeutics on Wikipedia, Google News & Yahoo Finance
• Arialys Therapeutics on LinkedIn, Twitter & YouTube

Call Arialys Therapeutics at +1 858...

View the org chart

Register to receive your alert

Report an error